AU3587797A - Methods of treatment of wasting syndrome based on administration of derivatives of human chorionic gonadotropin - Google Patents

Methods of treatment of wasting syndrome based on administration of derivatives of human chorionic gonadotropin

Info

Publication number
AU3587797A
AU3587797A AU35877/97A AU3587797A AU3587797A AU 3587797 A AU3587797 A AU 3587797A AU 35877/97 A AU35877/97 A AU 35877/97A AU 3587797 A AU3587797 A AU 3587797A AU 3587797 A AU3587797 A AU 3587797A
Authority
AU
Australia
Prior art keywords
administration
derivatives
treatment
methods
chorionic gonadotropin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35877/97A
Inventor
Joseph Bryant
Robert C. Gallo
Yanto Lunardi-Iskandar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland Biotechnology Institute UMBI
Original Assignee
University of Maryland Biotechnology Institute UMBI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland Biotechnology Institute UMBI filed Critical University of Maryland Biotechnology Institute UMBI
Publication of AU3587797A publication Critical patent/AU3587797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU35877/97A 1996-06-24 1997-06-24 Methods of treatment of wasting syndrome based on administration of derivatives of human chorionic gonadotropin Abandoned AU3587797A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US66967596A 1996-06-24 1996-06-24
US08669675 1996-06-24
US70993396A 1996-09-09 1996-09-09
US08709933 1996-09-09
PCT/US1997/011448 WO1997049721A1 (en) 1996-06-24 1997-06-24 Methods of treatment of wasting syndrome based on administration of derivatives of human chorionic gonadotropin

Publications (1)

Publication Number Publication Date
AU3587797A true AU3587797A (en) 1998-01-14

Family

ID=27100165

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35877/97A Abandoned AU3587797A (en) 1996-06-24 1997-06-24 Methods of treatment of wasting syndrome based on administration of derivatives of human chorionic gonadotropin

Country Status (2)

Country Link
AU (1) AU3587797A (en)
WO (1) WO1997049721A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1138692A1 (en) * 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragments of human chorionic gonadotropin (hcg) as immunoregulator
US7175679B2 (en) 2001-03-29 2007-02-13 Biotempt B.V. Oligopeptide treatment of NF-κB mediated inflammation
US6921751B1 (en) 1998-05-20 2005-07-26 Erasmus Universiteit Rotterdam Immunoregulator
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US7576174B2 (en) 2000-03-29 2009-08-18 Biotempt B.V. Compositions capable of reducing elevated blood urea concentration
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
EP1300418A1 (en) 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
US7202348B2 (en) * 2000-04-20 2007-04-10 The University Of Arkansas For Medical Sciences Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
FR2817752A1 (en) * 2000-12-07 2002-06-14 Georges Dreux Use of chorionic gonadotropin hormone to treat disorders in man and animals due to hepatic exocrine secretion, such as Crohn's disease, wasting disease, and diarrheic enteritis
US7501391B2 (en) 2001-12-21 2009-03-10 Biotempt B.V. Treatment of transplant survival
US7517529B2 (en) 2003-04-08 2009-04-14 Biotempt B.V. Treatment of type I diabetes
JP4846799B2 (en) 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． Tumor treatment
WO2009033661A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
EP2190450A2 (en) * 2007-09-11 2010-06-02 Mondobiotech Laboratories AG Use of melanin concentrating hormone and met-enkephalin as therapeutic agents
EP2109054A1 (en) 2008-04-09 2009-10-14 Biotempt B.V. Methods for identifying biologically active peptides and predicting their function
EP2490021A1 (en) 2011-02-18 2012-08-22 Biotempt B.V. Modulators of PRR and GPCR signalling

Also Published As

Publication number Publication date
WO1997049721A1 (en) 1997-12-31

Similar Documents

Publication Publication Date Title
AU3792497A (en) Methods of promoting hematopoiesis using derivatives of human chorionic gonadotropin
AU3581697A (en) Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
AU3587797A (en) Methods of treatment of wasting syndrome based on administration of derivatives of human chorionic gonadotropin
AU3879297A (en) Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin
EP0690039A3 (en) Poly-perfluoroalkyl-substituted alcohols and acids, and derivatives thereof
AU3866597A (en) Propionic acid derivatives and use thereof
AU3964697A (en) Method and device for stable impedance plethysmography
AU7391298A (en) Tetracyclic derivatives, process of preparation and use
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
AU4687600A (en) Device and method for the administration of oxygen
AU4161797A (en) Benzoperimidine-carboxylic acids and derivatives thereof
AU4071295A (en) 3-phenylisoquinol-1(2H)-one derivatives, their preparation and their therapeutic application
AU1442997A (en) Novel benzoyl guanidine derivatives, process for their preparation and their use in the preparation of medicines
AU4018897A (en) Novel 3,4-diaryloxazolone derivatives, methods of preparation and therapeutic uses thereof
AU1620395A (en) 13-substituted milbemycin derivatives, their preparation and use
AU1660297A (en) Process for the preparation of enantiomerically pure cycloalkano-indol -and azaindol -and pyrimido (1,2a) indol -carbocylic acids and their activated derivatives
AU1243399A (en) Imidazole derivatives, preparation and therapeutic application thereof
AU2030197A (en) 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
AU3853097A (en) Benzimidazole derivatives, preparation thereof, and therapeutical uses thereof
AU4062995A (en) 1-oxo-2-(phenylsulphonylamino) pentylpiperidine derivatives, their preparation and their therapeutic application
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU2401197A (en) Stabilization of interferons in aqueous solution for manufacture of sublingually administered tablets
AU3023497A (en) Phthalazine derivatives, their preparation and their use as drugs
AU3107497A (en) Asialotrisaccharide moranoline derivatives and drugs
AU1251295A (en) Substituted benzimidazole, processes for its preparation and its pharmaceutical use